Results 291 to 300 of about 676,827 (333)

Improving Genotype Imputation in High‐Dimensional Pharmacogenomics Using Multiple Imputation: Evaluation with Machine Learning Approaches

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Multiple imputation is well‐established for handling missing data, yet its use in high‐dimensional genetic datasets remains limited. Using pharmacokinetic tuberculosis simulations and SNP data (1000 Genomes Project), we compared machine learning (ML) and traditional approaches (e.g., mean imputation and complete‐case analysis) for imputation and ...
Innocent G. Asiimwe   +6 more
wiley   +1 more source

HLA

open access: yesTHE JOURNAL OF THE STOMATOLOGICAL SOCIETY,JAPAN, 1984
openaire   +2 more sources

Harnessing the immunomodulatory properties of HLA-G for advanced immunotherapies. [PDF]

open access: yesFront Immunol
Beli X   +5 more
europepmc   +1 more source

Modulation of the PGRMC1/NLRP7/HLA-C axis by autophagy is linked to both spontaneous preterm birth and gestational choriocarcinoma

open access: hybrid
Q. Li   +12 more
openalex   +1 more source

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes   +4 more
wiley   +1 more source

HLA and T-Cell Receptor Investigations in Idiopathic and Paraneoplastic Opsoclonus-Myoclonus in Children. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Olivé-Cirera G   +12 more
europepmc   +1 more source

HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer. [PDF]

open access: yesOncoimmunology
Ruiz-Lorente I   +14 more
europepmc   +1 more source

Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score. [PDF]

open access: yesDiabetes
Deutsch AJ   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy